Arkolith/Insider Trading/ADMA/Form 4

Kestenberg-Messina Kaitlin M.

COO and SVP, ComplianceADMA BIOLOGICS, INC. (ADMA) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$158K
Net Open-Market Flow
-$158K
Transactions
14
9 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Option exercise(M)2K$1.55$3K477K
Mar 9, 2026Option exercise(M)2K$2.35$4K475K
Mar 9, 2026Other(J)91K—$0467K
Mar 9, 2026Option exercise(M)3K$5.00$13K469K
Mar 9, 2026Option exercise(M)1K$4.31$5K470K
Mar 9, 2026Option exercise(M)3K$2.83$7K473K
Mar 9, 2026Sell(S)10K$15.63$158K467K
Mar 7, 2026Tax withholding(F)4K$15.39$65K558K
Mar 6, 2026Tax withholding(F)10K$15.39$155K562K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Option exercise(M)3K—$03K
Mar 9, 2026Option exercise(M)2K—$03K
Mar 9, 2026Option exercise(M)1K—$01K
Mar 9, 2026Option exercise(M)3K—$03K
Mar 9, 2026Option exercise(M)2K—$02K

Transaction Codes

M
Option exercise / conversion
J
Other acquisition / disposition
S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-008905) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML